Chris Hatwig is president of Apexus, the nation's leader in the advancement of ambulatory pharmacy solutions and the support of compliant 340B programs, since 2004. Apexus is best known for its role as Health Resources and Services Administration’s contracted 340B Prime Vendor, serving all 340B stakeholders. Throughout his career, Chris has been committed to developing and implementing solutions to improve efficient access to affordable medications between 340B stakeholders and the patients they support.
Before joining Apexus, Chris was the director of Ambulatory Pharmacy Services and Value Analysis Programs at Parkland Health & Hospital System in Dallas, where he practiced for 13 years, managing one of the nation’s largest and most progressive safety net ambulatory pharmacy programs. Mr. Hatwig received his bachelor’s degree in pharmacy from the University of Arkansas. He completed residencies in hospital pharmacy and hospital pharmacy administration at the University of Wisconsin, culminating in an MS in hospital pharmacy.